Effect of infection on lipid profile: focus on Epstein–Barr virus

Bibliography

• O’Connor S, Taylor C, Campbell LA, Epstein S, Libby P: Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg. Infect. Dis. 7, 780–788 (2001).
   Google Scholar
• Gibson FC III, Genco CA: Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.Curr. Pharm. Des. 13, 3665–3675 (2007).
   Google Scholar
• Gasbarrini A, Cremonini F, Armuzzi A et al.: The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases. J. Physiol. Pharmacol. 50, 735–742 (1999).
   Google Scholar
• Campbell LA, Kuo CC: Chlamydia pneumoniae – an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2, 23–32 (2004).
   Google Scholar
• Adam E, Melnick JL, Debakey ME: Cytomegalovirus infection and atherosclerosis.Cent. Eur. J. Public Health 5, 99–106 (1997).
   Google Scholar
• Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 74, 1045–1052 (1992).
   Google Scholar
• Espinola-Klein C, Rupprecht HJ, Blankenberg S et al.: Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33, 2581–2586 (2002).
   Google Scholar
• Boddi M, Abbate R, Chellini B et al.: HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques.Dig. Liver Dis. 39(Suppl. 1), S55–S60 (2007).
   Google Scholar
• Alyan O, Kacmaz F, Ozdemir O et al.: Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ. J. 72, 1960–1965 (2008).
   Google Scholar
• Espinola-Klein C, Rupprecht HJ, Blankenberg S et al.: Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105, 15–21 (2002).
   Google Scholar
• Farrugia PM, Lucariello R, Coppola JT: Human immunodeficiency virus and atherosclerosis.Cardiol. Rev. 17, 211–215 (2009).
   Google Scholar
• Hendrix MG, Salimans MM, Van Boven CP, Bruggeman CA: High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.Am. J. Pathol. 136, 23–28 (1990).
   Google Scholar
• Haidari M, Wyde PR, Litovsky S et al.: Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis 208(1), 90–96(2010).
   Google Scholar
• Speir E, Modali R, Huang ES et al.: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391–394 (1994).
   Google Scholar
• Normann SJ, Salomon DR, Leelachaikul P et al.: Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection. J. Heart Lung. Transplant. 10, 674–687 (1991).
   Google Scholar
• Shi Y, Tokunaga O: Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with nonatherosclerotic aortic tissue. Pathol. Int. 52, 31–39 (2002).
   Google Scholar
• Ibrahim AI, Obeid MT, Jouma MJ et al.: Detection of herpes simplex virus, cytomegalovirus and Epstein–Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J. Clin. Virol. 32, 29–32 (2005).
   Google Scholar
• Nicholson AC, Hajjar DP: Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler. Thromb. Vasc. Biol. 18, 339–348 (1998).
   Google Scholar
• Roivainen M, Viik-Kajander M, Palosuo T et al.: Infections, inflammation, and the risk of coronary heart disease. Circulation 101, 252–257 (2000).
   Google Scholar
• Khairy P, Rinfret S, Tardif JC et al.: Absence of association between infectious agents and endothelial function in healthy young men.Circulation 107, 1966–1971 (2003).
   Google Scholar
• Schlitt A, Blankenberg S, Weise K et al.: Herpesvirus DNA (Epstein–Barr virus, herpes simplex virus, cytomegalovirus) in circulating monocytes of patients with coronary artery disease. Acta Cardiol. 60, 605–610 (2005).
   Google Scholar
• Szklo M, Ding J, Tsai MY et al.: Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. J. Cardiovasc. Med. 10(10), 747–751 (2009).
   Google Scholar
• Voorend M, Van Der Ven AJ, Kubat B, Lodder J, Bruggeman CA: Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis. Open. Neurol. J. 2, 39–44 (2008).
   Google Scholar
• Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE: Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103, 45–51 (2001).
   Google Scholar
• Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100, E20–E28 (1999).
   Google Scholar
• Zhu J, Quyyumi AA, Norman JE et al.: Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am. J. Cardiol. 85, 140–146 (2000).
   Google Scholar
• Khovidhunkit W, Kim MS, Memon RA et al.: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.J. Lipid Res. 45, 1169–1196 (2004).
   Google Scholar
• Barlage S, Frohlich D, Bottcher A et al.: ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J. Lipid Res. 42, 281–290 (2001).
   Google Scholar
• Liberopoulos E, Alexandridis G, Bairaktari E, Elisaf M: Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis. Ann. Clin. Lab. Sci. 32, 305–308 (2002).
   Google Scholar
• Mooser V, Berger MM, Tappy L et al.: Major reduction in plasma Lp(a) levels during sepsis and burns. Arterioscler. Thromb. Vasc. Biol. 20, 1137–1142 (2000).
   Google Scholar
• Wu A, Hinds CJ, Thiemermann C: High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 21, 210–221 (2004).
   Google Scholar
• Liberopoulos E, Apostolou F, Elisaf M: Serum lipid profile in patients with severe leptospirosis. Nephrol. Dial. Transplant. 19, 1328–1329; author reply 1329–1330 (2004).
   Google Scholar
• Van Leeuwen HJ, Heezius EC, Dallinga GM, Van Strijp JA, Verhoef J, Van Kessel KP: Lipoprotein metabolism in patients with severe sepsis. Crit. Care Med. 31, 1359–1366 (2003).
   Google Scholar
• Van Leeuwen HJ, Van Beek AP, Dallinga-Thie GM, Van Strijp JA, Verhoef J, Van Kessel KP: The role of high density lipoprotein in sepsis. Neth. J. Med. 59, 102–110 (2001).
   Google Scholar
• Fraunberger P, Hahn J, Holler E, Walli AK, Seidel D: Serum cholesterol levels in neutropenic patients with fever. Clin. Chem. Lab. Med. 40, 304–307 (2002).
   Google Scholar
• Apostolou F, Gazi IF, Kostoula A et al.: Persistence of an atherogenic lipid profile after treatment of acute infection with brucella. J. Lipid Res. 50, 2532–2539 (2009).
   Google Scholar
• Gazi IF, Tsimihodimos V, Tselepis AD, Elisaf M, Mikhailidis DP: Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles. Expert Opin. Biol. Ther. 7, 53–72 (2007).
   Google Scholar
• Rufail ML, Schenkein HA, Barbour SE, Tew JG, Van Antwerpen R: Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis. J. Lipid Res. 46, 2752–2760 (2005).
   Google Scholar
• Badiou S, Merle De Boever C, Dupuy AM, Baillat V, Cristol JP, Reynes J: Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity? Atherosclerosis 168, 107–113 (2003).
   Google Scholar
• Tellis CC, Tselepis AD: The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim. Biophys. Acta 1791, 327–338 (2009).
   Google Scholar
• Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C: In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am. J. Physiol. 277, R94–R103 (1999).
   Google Scholar
• Khovidhunkit W, Memon RA, Shigenaga JK et al.: Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.Metabolism 48, 1524–1531 (1999).
   Google Scholar
• Trimoreau F, Francois B, Desachy A, Besse A, Vignon P, Denizot Y: Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome. Mediators Inflamm. 9, 197–200 (2000).
   Google Scholar
• Endo S, Inada K, Yamashita H et al.: Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis. Res. Commun. Chem. Pathol. Pharmacol. 83, 289–295 (1994).
   Google Scholar
• Takakuwa T, Endo S, Nakae H et al.: Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis.Res. Commun. Chem. Pathol. Pharmacol. 84, 271–281 (1994).
   Google Scholar
• Karasawa K, Harada A, Satoh N, Inoue K, Setaka M: Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog. Lipid Res. 42, 93–114 (2003).
   Google Scholar
• Graham RM, Stephens CJ, Silvester W, Leong LL, Sturm MJ, Taylor RR: Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit. Care Med. 22, 204–212 (1994).
   Google Scholar
• Howard KM, Olson MS: The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats.J. Biol. Chem. 275, 19891–19896 (2000).
   Google Scholar
• Mackness MI, Mackness B, Durrington PN: Paraoxonase and coronary heart disease.Atheroscler. Suppl. 3, 49–55 (2002).
   Google Scholar
• Feingold KR, Memon RA, Moser AH, Grunfeld C: Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.Atherosclerosis 139, 307–315 (1998).
   Google Scholar
• Van Lenten BJ, Hama SY, De Beer FC et al.: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96, 2758–2767 (1995).
   Google Scholar
• Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM: High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 103, 2283–2288 (2001).
   Google Scholar
• Jones K, Rivera C, Sgadari C et al.: Infection of human endothelial cells with Epstein–Barr virus. J. Exp. Med. 182, 1213–1221 (1995).
   Google Scholar
• Kempe S, Heinz P, Kokai E, Devergne O, Marx N, Wirth T: Epstein–Barr virus-induced gene-3 is expressed in human atheroma plaques. Am. J. Pathol. 175, 440–447 (2009).
   Google Scholar
• Apostolou F, Gazi IF, Lagos K et al.: Acute infection with Epstein–Barr virus is associated with atherogenic lipid changes.Atherosclerosis DOI: 10.1016/j.atherosclerosis.2010.06.006 (2010) (Epub ahead of print).
   Google Scholar